retatrutide news october 2025 A new clinical trial from Eli Lilly and Company suggests its experimental triple hormone drug, retatrutide, could become one of the next major medications in the rapidly growing weight loss and diabetes Lilly's Retatrutide Displays Positive Topline

All available safety information derives from regulated clinical trials conducted under investigational new drug frameworks, primarily sponsored by Eli Lilly and Company

Products like Ozempic and Wegovy are GLP-1 drugs, named after the hormone they mimic and which is activated by food intake

Its crucial to remember that individual responses to medications vary significantly

[DOI] [PubMed] [Google Scholar] 19.American Diabetes Association Comprehensive medical evaluation and assessment of comorbidities

The above figures are based on data compiled from multiple Irish pharmacies (including online sources) in late 2024 actual prices may vary slightly by pharmacy and over time